HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extramedullary hematopoiesis on 18F-FDG PET/CT in a patient with thalassemia and nasopharyngeal carcinoma: A case report and literature review.

Abstract
Extramedullary hematopoiesis (EMH) occurs in various bone marrow disorders and is most commonly seen in thalassemia and myelofibrosis. Here, we report a patient with beta-thalassemia and nasopharyngeal carcinoma having intrathoracic EMH. Our patient is a 42-year-old man who complained of chest discomfort for a month. He was confirmed nasopharyngeal carcinoma (T3N2M0) by histopathology and received chemoradiotherapy 4 months ago. The patient had a long history of beta-thalassemia and a splenectomy due to splenomegaly at 12 years of age. Computed tomography (CT) scan of the chest showed multiple soft tissue masses in bilateral thoracic cavities. 18F-FDG-PET showed no obvious increase of fluorodeoxyglucose (18F-FDG) uptake by the lesions, with an SUVmax value of approximately 2.19. These lesions were considered EMH. The patient had been followed up for more than 1 year, and there were no changes of the lesions in the thoracic cavities.
AuthorsDasheng Qiu, Xiaoyan Hu, Liying Xu, Xiaofang Guo
JournalJournal of cancer research and therapeutics (J Cancer Res Ther) 2015 Oct-Dec Vol. 11 Issue 4 Pg. 1034 ISSN: 1998-4138 [Electronic] India
PMID26881631 (Publication Type: Case Reports, Letter, Review)
Chemical References
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
Topics
  • Adult
  • Carcinoma
  • Fluorodeoxyglucose F18
  • Hematopoiesis, Extramedullary
  • Humans
  • Male
  • Multimodal Imaging (methods)
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms (complications, pathology)
  • Positron-Emission Tomography (methods)
  • Prognosis
  • Radiopharmaceuticals
  • Thalassemia (complications, pathology)
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: